1. Home
  2. IDYA vs HURN Comparison

IDYA vs HURN Comparison

Compare IDYA & HURN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo IDEAYA Biosciences Inc.

IDYA

IDEAYA Biosciences Inc.

N/A

Current Price

$31.03

Market Cap

3.6B

Sector

Health Care

ML Signal

N/A

Logo Huron Consulting Group Inc.

HURN

Huron Consulting Group Inc.

N/A

Current Price

$168.75

Market Cap

2.9B

ML Signal

N/A

Company Overview

Basic Information
Metric
IDYA
HURN
Founded
2015
2002
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Professional Services
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
3.6B
2.9B
IPO Year
2019
2004

Fundamental Metrics

Financial Performance
Metric
IDYA
HURN
Price
$31.03
$168.75
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
16
5
Target Price
$51.54
★ $202.00
AVG Volume (30 Days)
★ 986.4K
446.2K
Earning Date
11-03-2026
11-03-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 61.90
N/A
EPS
N/A
★ 4.96
Revenue
$218,710,000.00
★ $1,699,143,000.00
Revenue This Year
N/A
$12.58
Revenue Next Year
$216.42
$8.98
P/E Ratio
★ N/A
$34.88
Revenue Growth
★ 3024.43
11.65
52 Week Low
$26.81
$84.88
52 Week High
$42.68
$203.37

Technical Indicators

Market Signals
Indicator
IDYA
HURN
Relative Strength Index (RSI) 33.78 40.91
Support Level $29.74 $119.02
Resistance Level $35.44 $171.46
Average True Range (ATR) 1.53 9.08
MACD -0.21 -3.19
Stochastic Oscillator 4.75 15.08

Price Performance

Historical Comparison
IDYA
HURN

About IDYA IDEAYA Biosciences Inc.

IDEAYA Biosciences Inc is an oncology-focused precision medicine company committed to the discovery and development of targeted therapeutics for patient populations selected using molecular diagnostics. Its approach integrates small molecule drug discovery with extensive capabilities in identifying and validating translational biomarkers to develop targeted therapies for select patient populations that are likely to benefit from these targeted therapies. The company's clinical-stage product candidates include darovasertib (PKC), IDE397 (MAT2A), IDE849 (DLL3), IDE275 (Werner Helicase), IDE161 (PARG), and IDE705 (Pol Theta Helicase). In addition, it also working on other development candidates and has multiple earlier-stage preclinical programs.

About HURN Huron Consulting Group Inc.

Huron Consulting Group Inc is a professional services firm. The company provides expertise in technology, operations, advisory services, & analytics through three operating segments namely Healthcare, Education, and Commercial. Healthcare segment helps the firms to transform and innovate the delivery model to focus on patient wellness by improving quality outcomes, minimizing care variation and fundamentally improving patient and population health, Education segment provides management consulting and technology solutions, and Commercial segment is focused on serving industries and organizations facing disruption and regulatory change. It generates a majority of its revenue from the Healthcare Segment.

Share on Social Networks: